Keros Therapeutics, Inc.
US ˙ NasdaqGM ˙ US4923271013

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Julius Knowles. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Julius Knowles telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:KROS / Keros Therapeutics, Inc. Director 6,441
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Julius Knowles. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam KROS / Keros Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di KROS / Keros Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2020-04-13 KROS Knowles Julius 1,191 20.9800 1,191 20.9800 24,987 248 82.74 73,556 294.38

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

KROS / Keros Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam KROS / Keros Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di KROS / Keros Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

KROS / Keros Therapeutics, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Julius Knowles sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-06-06 2025-06-04 4 KROS Keros Therapeutics, Inc.
Common Stock
A - Award 5,250 6,441 440.81
2023-01-20 2020-04-13 4 KROS Keros Therapeutics, Inc.
Common Stock
P - Purchase 1,191 1,191 20.98 24,987 24,987
2022-01-05 2022-01-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -435 232,727 -0.19 59.00 -25,665 13,730,893
2022-01-05 2022-01-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -667 341,574 -0.19 59.00 -39,353 20,152,866
2022-01-05 2022-01-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -886 233,162 -0.38 58.20 -51,565 13,570,028
2022-01-05 2022-01-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,356 342,241 -0.39 58.20 -78,919 19,918,426
2022-01-05 2022-01-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -271 234,048 -0.12 57.23 -15,509 13,394,567
2022-01-05 2022-01-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -419 343,597 -0.12 57.23 -23,979 19,664,056
2022-01-05 2022-01-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,195 234,319 -0.93 58.86 -129,198 13,792,016
2022-01-05 2022-01-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,367 344,016 -0.97 58.86 -198,182 20,248,782
2022-01-05 2022-01-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,704 236,514 -1.13 57.99 -156,805 13,715,447
2022-01-05 2022-01-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -4,151 347,383 -1.18 57.99 -240,716 20,144,740
2022-01-05 2022-01-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,113 239,218 -0.46 56.95 -63,385 13,623,465
2022-01-05 2022-01-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,707 351,534 -0.48 56.95 -97,214 20,019,861
2022-01-05 2022-01-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,383 240,331 -0.57 56.10 -77,586 13,482,569
2022-01-05 2022-01-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,124 353,241 -0.60 56.10 -119,156 19,816,820
2022-01-05 2022-01-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -524 241,714 -0.22 54.95 -28,794 13,282,184
2022-01-05 2022-01-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -794 355,365 -0.22 54.95 -43,630 19,527,307
2022-01-05 2022-01-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -162 242,238 -0.07 59.40 -9,623 14,388,937
2022-01-05 2022-01-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -249 356,159 -0.07 59.40 -14,791 21,155,845
2022-01-05 2022-01-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,412 242,400 -1.39 58.96 -201,172 14,291,904
2022-01-05 2022-01-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -5,236 356,408 -1.45 58.96 -308,715 21,013,816
2022-01-05 2022-01-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,318 245,812 -1.33 57.83 -191,880 14,215,308
2022-01-05 2022-01-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -5,094 361,644 -1.39 57.83 -294,586 20,913,873
2022-01-05 2022-01-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,406 249,130 -0.96 56.82 -136,709 14,155,567
2022-01-05 2022-01-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,678 366,738 -0.99 56.82 -208,984 20,838,053
2021-12-03 2021-12-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -90 251,536 -0.04 54.67 -4,920 13,751,473
2021-12-03 2021-12-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -138 370,416 -0.04 54.67 -7,544 20,250,643
2021-12-03 2021-12-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -5,705 251,626 -2.22 53.86 -307,271 13,552,576
2021-12-03 2021-12-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -8,747 370,554 -2.31 53.86 -471,113 19,958,038
2021-12-03 2021-12-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -4,155 257,331 -1.59 53.17 -220,921 13,682,289
2021-12-03 2021-12-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -6,372 379,301 -1.65 53.17 -338,799 20,167,434
2021-12-03 2021-12-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -52 261,486 -0.02 52.00 -2,704 13,597,272
2021-12-03 2021-12-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -79 385,673 -0.02 51.99 -4,107 20,051,139
2021-12-03 2021-12-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,021 261,538 -0.39 56.27 -57,452 14,716,743
2021-12-03 2021-12-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,566 385,752 -0.40 56.27 -88,119 21,706,265
2021-12-03 2021-12-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,649 262,559 -0.62 55.71 -91,866 14,627,162
2021-12-03 2021-12-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,528 387,318 -0.65 55.71 -140,835 21,577,486
2021-12-03 2021-12-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,372 264,208 -1.26 54.67 -184,347 14,444,251
2021-12-03 2021-12-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -5,168 389,846 -1.31 54.67 -282,535 21,312,881
2021-12-03 2021-12-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,766 267,580 -1.02 53.48 -147,926 14,310,178
2021-12-03 2021-12-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -4,243 395,014 -1.06 53.48 -226,916 21,125,349
2021-11-03 2021-11-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,346 270,346 -0.86 42.45 -99,588 11,476,188
2021-11-03 2021-11-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,597 399,257 -0.89 42.45 -152,693 16,948,460
2021-11-03 2021-11-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,957 272,692 -1.43 41.65 -164,809 11,357,622
2021-11-03 2021-11-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -6,067 402,854 -1.48 41.65 -252,691 16,778,869
2021-11-03 2021-11-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -991 276,649 -0.36 43.04 -42,653 11,906,973
2021-11-03 2021-11-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,518 408,921 -0.37 43.04 -65,335 17,599,960
2021-11-03 2021-11-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,120 277,640 -0.76 42.10 -89,252 11,688,644
2021-11-03 2021-11-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,252 410,439 -0.79 42.10 -136,909 17,279,482
2021-11-03 2021-11-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -4,797 279,760 -1.69 42.43 -203,537 11,870,217
2021-11-03 2021-11-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -7,350 413,691 -1.75 42.43 -311,860 17,552,909
2021-11-03 2021-11-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -4,599 284,557 -1.59 41.85 -192,468 11,908,710
2021-11-03 2021-11-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -7,057 421,041 -1.65 41.85 -295,335 17,620,566
2021-10-21 2021-10-20 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,463 289,156 -0.50 38.31 -56,048 11,077,566
2021-10-21 2021-10-20 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,242 428,098 -0.52 38.31 -85,891 16,400,434
2021-10-21 2021-10-20 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -148 290,619 -0.05 37.55 -5,557 10,912,743
2021-10-21 2021-10-20 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -229 430,340 -0.05 37.55 -8,599 16,159,267
2021-10-21 2021-10-19 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -460 290,767 -0.16 38.49 -17,705 11,191,622
2021-10-21 2021-10-19 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -704 430,569 -0.16 38.49 -27,097 16,572,601
2021-10-21 2021-10-19 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,323 291,227 -0.45 38.05 -50,340 11,081,187
2021-10-21 2021-10-19 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,029 431,273 -0.47 38.05 -77,203 16,409,938
2021-10-18 2021-10-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -60 292,550 -0.02 38.46 -2,308 11,251,473
2021-10-18 2021-10-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -92 433,302 -0.02 38.46 -3,538 16,664,795
2021-10-18 2021-10-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -5,382 292,610 -1.81 37.69 -202,848 11,028,471
2021-10-18 2021-10-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -8,252 433,394 -1.87 37.69 -311,018 16,334,620
2021-10-18 2021-10-15 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -60 297,992 -0.02 40.60 -2,436 12,098,475
2021-10-18 2021-10-15 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -92 441,646 -0.02 40.60 -3,735 17,930,828
2021-10-18 2021-10-15 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,199 298,052 -0.40 39.44 -47,289 11,755,171
2021-10-18 2021-10-15 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,839 441,738 -0.41 39.44 -72,530 17,422,147
2021-10-18 2021-10-15 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,977 299,251 -0.66 38.95 -77,004 11,655,826
2021-10-18 2021-10-15 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,031 443,577 -0.68 38.95 -118,057 17,277,324
2021-10-18 2021-10-14 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,730 301,228 -0.57 40.13 -69,425 12,088,280
2021-10-18 2021-10-14 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,653 446,608 -0.59 40.13 -106,465 17,922,379
2021-10-05 2021-10-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,033 302,958 -0.34 40.03 -41,351 12,127,409
2021-10-05 2021-10-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,584 449,261 -0.35 40.03 -63,408 17,983,918
2021-10-05 2021-10-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,479 303,991 -0.48 40.06 -59,249 12,177,879
2021-10-05 2021-10-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,267 450,845 -0.50 40.06 -90,816 18,060,851
2021-10-05 2021-10-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,496 305,470 -0.81 40.16 -100,239 12,267,675
2021-10-05 2021-10-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,827 453,112 -0.84 40.16 -153,692 18,196,978
2021-09-29 2021-09-27 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -6,532 307,966 -2.08 42.29 -276,238 13,023,882
2021-09-29 2021-09-27 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -10,018 456,939 -2.15 42.29 -423,661 19,323,950
2021-09-29 2021-09-27 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -13,233 314,498 -4.04 41.52 -549,434 13,057,957
2021-09-29 2021-09-27 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -20,292 466,957 -4.16 41.52 -842,524 19,388,055
2021-09-29 2021-09-27 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -17,854 327,731 -5.17 40.51 -723,266 13,276,383
2021-09-29 2021-09-27 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -27,373 487,249 -5.32 40.51 -1,108,880 19,738,457
2021-07-06 2021-07-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,776 345,585 -1.08 41.72 -157,535 14,417,806
2021-07-06 2021-07-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -5,789 514,622 -1.11 41.72 -241,517 21,470,030
2021-07-06 2021-07-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -5,626 349,361 -1.58 41.08 -231,116 14,351,750
2021-07-06 2021-07-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -8,627 520,411 -1.63 41.08 -354,397 21,378,484
2021-07-06 2021-07-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -30 354,987 -0.01 42.75 -1,282 15,175,694
2021-07-06 2021-07-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -46 529,038 -0.01 42.75 -1,966 22,616,374
2021-07-06 2021-07-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -728 355,017 -0.20 41.89 -30,496 14,871,662
2021-07-06 2021-07-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,112 529,084 -0.21 41.89 -46,582 22,163,329
2021-07-06 2021-07-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -8,650 355,745 -2.37 41.22 -356,553 14,663,809
2021-07-06 2021-07-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -13,268 530,196 -2.44 41.22 -546,907 21,854,679
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -560 364,395 -0.15 51.46 -28,818 18,751,767
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -858 543,464 -0.16 51.46 -44,153 27,966,657
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,586 364,955 -0.70 50.80 -131,369 18,539,714
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,968 544,322 -0.72 50.80 -201,574 27,651,558
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -568 367,541 -0.15 50.02 -28,411 18,384,401
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -870 548,290 -0.16 50.02 -43,517 27,425,466
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -366 368,109 -0.10 48.76 -17,846 17,948,995
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -560 549,160 -0.10 48.76 -27,306 26,777,042
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -512 368,475 -0.14 47.34 -24,238 17,443,606
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -786 549,720 -0.14 47.34 -37,209 26,023,745
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -459 368,987 -0.12 46.48 -21,334 17,150,516
2021-06-08 2021-06-07 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -703 550,506 -0.13 46.48 -32,675 25,587,519
2021-06-08 2021-06-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -663 369,446 -0.18 48.15 -31,923 17,788,825
2021-06-08 2021-06-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,018 551,209 -0.18 48.15 -49,017 26,540,713
2021-06-08 2021-06-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,950 370,109 -0.52 47.23 -92,098 17,480,248
2021-06-08 2021-06-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,988 552,227 -0.54 47.23 -141,123 26,081,681
2021-06-03 2021-06-01 4 KROS Keros Therapeutics, Inc.
Stock Option (right to buy)
A - Award 8,293 8,293
2021-06-03 2021-06-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,903 372,059 -0.51 48.15 -91,629 17,914,641
2021-06-03 2021-06-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,917 555,215 -0.52 48.15 -140,454 26,733,602
2021-06-03 2021-06-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,213 373,962 -0.32 47.69 -57,848 17,834,248
2021-06-03 2021-06-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,862 558,132 -0.33 47.69 -88,799 26,617,315
2021-06-03 2021-06-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -91 375,175 -0.02 51.45 -4,682 19,302,754
2021-06-03 2021-06-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -138 559,994 -0.02 51.45 -7,100 28,811,691
2021-06-03 2021-06-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -361 375,266 -0.10 50.52 -18,238 18,958,438
2021-06-03 2021-06-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -553 560,132 -0.10 50.52 -27,938 28,297,869
2021-06-03 2021-06-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -874 375,627 -0.23 49.26 -43,053 18,503,386
2021-06-03 2021-06-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,343 560,685 -0.24 49.26 -66,156 27,619,343
2021-06-03 2021-06-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,225 376,501 -0.85 48.35 -155,929 18,203,823
2021-06-03 2021-06-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -4,944 562,028 -0.87 48.35 -239,042 27,174,054
2021-06-03 2021-06-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -30 379,726 -0.01 54.62 -1,639 20,740,634
2021-06-03 2021-06-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -46 566,972 -0.01 54.62 -2,513 30,968,011
2021-06-03 2021-06-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -414 379,756 -0.11 53.77 -22,261 20,419,480
2021-06-03 2021-06-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -633 567,018 -0.11 53.77 -34,036 30,488,558
2021-06-03 2021-06-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,531 380,170 -0.40 52.72 -80,714 20,042,562
2021-06-03 2021-06-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,345 567,651 -0.41 52.72 -123,628 29,926,561
2021-06-03 2021-06-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,504 381,701 -0.39 51.90 -78,058 19,810,282
2021-06-03 2021-06-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,309 569,996 -0.40 51.90 -119,837 29,582,792
2021-05-05 2021-05-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -339 383,205 -0.09 54.35 -18,425 20,827,192
2021-05-05 2021-05-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -520 572,305 -0.09 54.35 -28,262 31,104,777
2021-05-05 2021-05-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -780 383,544 -0.20 53.73 -41,909 20,607,819
2021-05-05 2021-05-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,196 572,825 -0.21 53.73 -64,261 30,777,887
2021-05-05 2021-05-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -616 384,324 -0.16 59.48 -36,640 22,859,592
2021-05-05 2021-05-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -942 574,021 -0.16 59.48 -56,030 34,142,769
2021-05-05 2021-05-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -4,506 384,940 -1.16 58.78 -264,863 22,626,773
2021-05-05 2021-05-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -6,905 574,963 -1.19 58.78 -405,876 33,796,325
2021-05-05 2021-05-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -4,600 389,446 -1.17 57.86 -266,156 22,533,346
2021-05-05 2021-05-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -7,054 581,868 -1.20 57.86 -408,144 33,666,882
2021-05-05 2021-05-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -4,460 394,046 -1.12 56.63 -252,570 22,314,825
2021-05-05 2021-05-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -6,841 588,922 -1.15 56.63 -387,406 33,350,653
2021-05-05 2021-05-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,509 398,506 -0.87 56.04 -196,644 22,332,276
2021-05-05 2021-05-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -5,383 595,763 -0.90 56.04 -301,663 33,386,559
2021-04-08 2021-04-06 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -35 402,015 -0.01 59.95 -2,098 24,100,799
2021-04-08 2021-04-06 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -54 601,146 -0.01 59.95 -3,237 36,038,703
2021-04-08 2021-04-06 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,402 402,050 -0.59 59.10 -141,958 23,761,155
2021-04-08 2021-04-06 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,685 601,200 -0.61 59.10 -217,784 35,530,920
2021-04-08 2021-04-06 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,233 404,452 -0.30 58.22 -71,785 23,547,195
2021-04-08 2021-04-06 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,889 604,885 -0.31 58.22 -109,978 35,216,405
2021-04-05 2021-04-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -6,972 405,685 -1.69 60.26 -420,133 24,446,578
2021-04-05 2021-04-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -10,690 606,774 -1.73 60.26 -644,179 36,564,201
2021-04-05 2021-04-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,551 412,657 -0.85 59.76 -212,208 24,660,382
2021-04-05 2021-04-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -5,445 617,464 -0.87 59.76 -325,393 36,899,649
2021-04-05 2021-04-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -195 416,208 -0.05 58.66 -11,439 24,414,761
2021-04-05 2021-04-05 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -298 622,909 -0.05 58.66 -17,481 36,539,842
2021-04-05 2021-04-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -134 416,403 -0.03 61.36 -8,222 25,550,488
2021-04-05 2021-04-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -206 623,207 -0.03 61.36 -12,640 38,239,982
2021-04-05 2021-04-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -283 416,537 -0.07 60.82 -17,212 25,333,780
2021-04-05 2021-04-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -434 623,413 -0.07 60.82 -26,396 37,915,979
2021-04-05 2021-04-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,533 416,820 -0.37 59.08 -90,570 24,625,726
2021-04-05 2021-04-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,350 623,847 -0.38 59.08 -138,838 36,856,881
2021-04-05 2021-04-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,472 418,353 -0.59 58.42 -144,414 24,440,182
2021-04-05 2021-04-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,790 626,197 -0.60 58.42 -221,412 36,582,429
2021-03-05 2021-03-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -126 420,825 -0.03 58.03 -7,312 24,420,475
2021-03-05 2021-03-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -193 629,987 -0.03 58.03 -11,200 36,558,146
2021-03-05 2021-03-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -553 420,951 -0.13 57.21 -31,637 24,082,607
2021-03-05 2021-03-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -847 630,180 -0.13 57.21 -48,457 36,052,598
2021-03-05 2021-03-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -895 421,504 -0.21 56.18 -50,281 23,680,095
2021-03-05 2021-03-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,376 631,027 -0.22 56.18 -77,304 35,451,097
2021-03-05 2021-03-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,932 422,399 -0.46 55.21 -106,666 23,320,649
2021-03-05 2021-03-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,962 632,403 -0.47 55.21 -163,532 34,914,970
2021-03-05 2021-03-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,086 424,331 -0.26 54.22 -58,883 23,007,227
2021-03-05 2021-03-04 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,662 635,365 -0.26 54.22 -90,114 34,449,490
2021-03-05 2021-03-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -496 425,417 -0.12 58.88 -29,204 25,048,553
2021-03-05 2021-03-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -761 637,027 -0.12 58.88 -44,808 37,508,150
2021-03-05 2021-03-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,894 425,913 -0.44 57.79 -109,454 24,613,512
2021-03-05 2021-03-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,903 637,788 -0.45 57.79 -167,764 36,857,769
2021-03-05 2021-03-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,958 427,807 -0.46 56.95 -111,508 24,363,609
2021-03-05 2021-03-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,004 640,691 -0.47 56.95 -171,078 36,487,352
2021-03-05 2021-03-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -518 429,765 -0.12 55.91 -28,961 24,028,161
2021-03-05 2021-03-03 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -793 643,695 -0.12 55.91 -44,337 35,988,987
2021-03-03 2021-03-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -90 430,283 -0.02 61.90 -5,571 26,634,518
2021-03-03 2021-03-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -138 644,488 -0.02 61.90 -8,542 39,893,807
2021-03-03 2021-03-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -361 430,373 -0.08 60.61 -21,880 26,084,908
2021-03-03 2021-03-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -554 644,626 -0.09 60.61 -33,578 39,070,782
2021-03-03 2021-03-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -686 430,734 -0.16 60.05 -41,194 25,865,577
2021-03-03 2021-03-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,052 645,180 -0.16 60.05 -63,173 38,743,059
2021-03-03 2021-03-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -714 431,420 -0.17 58.90 -42,055 25,410,638
2021-03-03 2021-03-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,095 646,232 -0.17 58.90 -64,496 38,063,065
2021-03-03 2021-03-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,377 432,134 -0.55 57.93 -137,700 25,033,523
2021-03-03 2021-03-02 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,644 647,327 -0.56 57.93 -211,097 37,499,653
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -30 434,511 -0.01 67.60 -2,028 29,372,944
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -46 650,971 -0.01 67.60 -3,110 44,005,640
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -516 434,541 -0.12 66.04 -34,077 28,697,088
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -792 651,017 -0.12 66.04 -52,304 42,993,163
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -479 435,057 -0.11 65.28 -31,269 28,400,521
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -734 651,809 -0.11 65.29 -47,923 42,556,610
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -406 435,536 -0.09 64.09 -26,021 27,913,502
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -625 652,543 -0.10 64.09 -40,056 41,821,481
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,169 435,942 -0.27 63.22 -73,904 27,560,253
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,794 653,168 -0.27 63.22 -113,417 41,293,281
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,473 437,111 -0.34 62.11 -91,488 27,148,964
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,257 654,962 -0.34 62.11 -140,182 40,679,690
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,050 438,584 -0.24 61.33 -64,396 26,898,357
2021-03-03 2021-03-01 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,608 657,219 -0.24 61.33 -98,619 40,307,241
2021-02-18 2021-02-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -75 439,634 -0.02 65.01 -4,876 28,580,606
2021-02-18 2021-02-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -116 658,827 -0.02 65.02 -7,542 42,836,932
2021-02-18 2021-02-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -552 439,709 -0.13 64.17 -35,422 28,216,127
2021-02-18 2021-02-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -845 658,943 -0.13 64.16 -54,215 42,277,783
2021-02-18 2021-02-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -205 440,261 -0.05 63.04 -12,923 27,754,053
2021-02-18 2021-02-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -315 659,788 -0.05 63.04 -19,858 41,593,036
2021-02-18 2021-02-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -180 440,466 -0.04 61.68 -11,102 27,167,943
2021-02-18 2021-02-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -276 660,103 -0.04 61.68 -17,024 40,715,153
2021-02-18 2021-02-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -150 440,646 -0.03 60.06 -9,009 26,465,199
2021-02-18 2021-02-18 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -230 660,379 -0.03 60.06 -13,814 39,662,363
2021-02-18 2021-02-17 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,705 440,796 -0.39 62.72 -106,938 27,646,725
2021-02-18 2021-02-17 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,613 660,609 -0.39 62.72 -163,887 41,433,396
2021-02-18 2021-02-17 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,201 442,501 -0.27 61.80 -74,222 27,346,562
2021-02-18 2021-02-17 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,841 663,222 -0.28 61.80 -113,774 40,987,120
2021-02-18 2021-02-17 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -764 443,702 -0.17 60.66 -46,344 26,914,963
2021-02-18 2021-02-17 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,173 665,063 -0.18 60.66 -71,154 40,342,722
2021-02-18 2021-02-17 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,249 444,466 -0.50 59.96 -134,850 26,650,181
2021-02-18 2021-02-17 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,449 666,236 -0.52 59.96 -206,802 39,947,511
2021-02-18 2021-02-17 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -421 446,715 -0.09 58.74 -24,730 26,240,039
2021-02-18 2021-02-17 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -645 669,685 -0.10 58.74 -37,887 39,337,297
2021-02-18 2021-02-16 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -90 447,136 -0.02 60.92 -5,483 27,239,525
2021-02-18 2021-02-16 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -138 670,330 -0.02 60.92 -8,407 40,836,504
2021-02-18 2021-02-16 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,609 447,226 -0.58 60.23 -157,140 26,936,422
2021-02-18 2021-02-16 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -3,999 670,468 -0.59 60.23 -240,860 40,382,288
2021-02-18 2021-02-16 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -661 449,835 -0.15 59.34 -39,224 26,693,209
2021-02-18 2021-02-16 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,014 674,467 -0.15 59.34 -60,171 40,022,872
2021-02-18 2021-02-16 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -434 450,496 -0.10 58.48 -25,380 26,345,006
2021-02-18 2021-02-16 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -667 675,481 -0.10 58.48 -39,006 39,502,129
2021-02-16 2021-02-12 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -30 450,930 -0.01 63.85 -1,916 28,791,880
2021-02-16 2021-02-12 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -46 676,148 -0.01 63.85 -2,937 43,172,050
2021-02-16 2021-02-12 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -531 450,960 -0.12 63.14 -33,527 28,473,614
2021-02-16 2021-02-12 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -814 676,194 -0.12 63.14 -51,396 42,694,889
2021-02-16 2021-02-12 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -641 451,491 -0.14 62.52 -40,075 28,227,217
2021-02-16 2021-02-12 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -985 677,008 -0.15 62.52 -61,582 42,326,540
2021-02-16 2021-02-12 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -913 452,132 -0.20 61.03 -55,720 27,593,616
2021-02-16 2021-02-12 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,397 677,993 -0.21 61.03 -85,259 41,377,913
2021-02-16 2021-02-12 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -833 453,045 -0.18 60.20 -50,147 27,273,309
2021-02-16 2021-02-12 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,278 679,390 -0.19 60.20 -76,936 40,899,278
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -35 453,878 -0.01 67.98 -2,379 30,854,626
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -53 680,668 -0.01 67.99 -3,603 46,278,617
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -206 453,913 -0.05 66.65 -13,730 30,253,301
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -316 680,721 -0.05 66.65 -21,061 45,370,055
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,575 454,119 -0.35 65.80 -103,635 29,881,030
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,418 681,037 -0.35 65.80 -159,104 44,812,235
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -952 455,694 -0.21 64.87 -61,756 29,560,870
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,461 683,455 -0.21 64.87 -94,775 44,335,726
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -1,526 456,646 -0.33 63.83 -97,405 29,147,714
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -2,335 684,916 -0.34 63.83 -149,043 43,718,188
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -270 458,172 -0.06 62.79 -16,953 28,768,620
2021-02-16 2021-02-11 4 KROS Keros Therapeutics, Inc.
Common Stock
S - Sale X -414 687,251 -0.06 62.79 -25,995 43,152,490
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -44,676 0 -100.00
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -67,015 0 -100.00
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Series B-1 Preferred Stock
C - Conversion -137,308 0 -100.00
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Series B-1 Preferred Stock
C - Conversion -205,962 0 -100.00
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -184,305 0 -100.00
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -276,459 0 -100.00
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Common Stock
C - Conversion 44,676 458,442 10.80
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Common Stock
C - Conversion 67,015 687,665 10.80
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Common Stock
C - Conversion 137,308 413,766 49.67
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Common Stock
C - Conversion 205,962 620,650 49.67
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Common Stock
C - Conversion 184,305 276,458 200.00
2020-04-13 2020-04-13 4 KROS Keros Therapeutics, Inc.
Common Stock
C - Conversion 276,459 414,688 200.00
2020-04-07 3 KROS Keros Therapeutics, Inc.
Common Stock
368,611
2020-04-07 3 KROS Keros Therapeutics, Inc.
Common Stock
322,535
2020-04-07 3 KROS Keros Therapeutics, Inc.
Common Stock
368,611
2020-04-07 3 KROS Keros Therapeutics, Inc.
Common Stock
322,535
2020-04-07 3 KROS Keros Therapeutics, Inc.
Common Stock
368,611
2020-04-07 3 KROS Keros Therapeutics, Inc.
Common Stock
322,535
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)